EGFR and neoplasm: For passive tumor targeting, we have created a functionalized siRNA delivery approach, GE11-siRNA-CSNPs, for targeting and inhibiting miRNA-21 expression as a method to effectively cause death in TNBC cells that overexpress the EGFR.